Discover how CRISPR genome editing is revolutionizing medicine. Learn the science of Cas9, current clinical trials, and the future of gene editing.

A team of researchers led by Feng Zhang at the Broad Institute of MIT and Harvard and the McGovern Institute for Brain Research at MIT has uncovered the first programmable RNA-guided system in ...

Nabsys and the Research Lab of Dr. Martin Taylor, Brown University, Present Data Using the OhmX™ Platform at AGBT 2026 EGM enables the direct detection of endonuclease activity at the genome scale by ...

Genome editing-based therapies typically aim to treat disease by correcting underlying genetic mutations in patient's cells.

Genetic disorders occur due to alterations in the primary genetic material—deoxyribonucleic acid (DNA)—of an organism. Transthyretin amyloidosis (ATTR) is a progressive disorder involving amyloid ...

Researchers are further improving CRISPR's versatility to engineer new grasses and yeasts for biochemical production. CRISPR/Cas systems have undergone tremendous advancement in the past decade. These ...

The Baylor/Rice Genome Editing Testing Center (GETC) offers researchers in vivo evaluation of genome editing activity, biodistribution and efficacy in mouse models as a fee-for-service. Our center ...